High MGMT expression and abnormal MMR function are mechanistically linked to TMZ resistance in multiple tumor models, and elevated MGMT expression or lack of MGMT promoter hypermethylation in patient tumor specimens is associated with a worse outcome in patients with GBM treated with TMZ. The gene discussed is MGMT; the disease is neoplasm.